Active ingredientAtosiban AcetateCat. No. P-A211-001CAS 914453-95-5Family · Pharmaceutical analytical standards
Atosiban
A peptide antagonist of oxytocin and vasopressin receptors, developed in Sweden in the 1980s and approved in Europe in 2000 to delay imminent preterm birth. This family brings together the active ingredient and other impurities.
Did you know?It is a modified analogue of oxytocin, the first peptide hormone ever synthesised in the laboratory: Vincent du Vigneaud achieved it in 1953 and won the 1955 Nobel Prize in Chemistry.
Go to the active ingredient →Active ingredientAtosiban AcetateCat. No. P-A211-001CAS 914453-95-5
ImpurityAtosiban Impurity 1 TrifluoroacetateCat. No. P-A211-007
ImpurityAtosiban Impurity 2 TrifluoroacetateCat. No. P-A211-008
ImpurityAtosiban Impurity 3Cat. No. P-A211-011
ImpurityAtosiban Impurity 4Cat. No. P-A211-013
ImpurityAtosiban Impurity DCat. No. P-A211-014
ImpurityAtosiban Impurity FCat. No. P-A211-015
ImpurityAtosiban Impurity GCat. No. P-A211-016
ImpurityAtosiban Impurity BCat. No. P-A211-017CAS 960411-86-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.